Returning for its second year, the Autoimmunity and Inflammation Partnering and Investment Summit unites over 80 on-scope and in-strategy companies to increase your success rate, efficiency, and collaborative outcomes. Unite to: Capitalize on protected face-to-face networking with a 100% aligned audience and the One-on-One Partnering system, to efficiently generate higher-yielding deal opportunities and nurture multiple key relationships in a less competitive forum Understand assessment criteria, data package expectations, and due diligence of pharma and investors, and hear invaluable feedback into your financing or development programs